Sterling Biotech Ltd

Sterling Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sterling Biotech Ltd

₹ 0.70 0.00%
05 Nov 2018
sterlingbiotech.in
About

Sterling Biotech is engaged in the manufacturing of Pharma Grade Gelatine & Di-Calcium Phosphate and other Pharma products The Company has presence in both domestic and international markets.

[ add key points ]
Website
  • Market Cap ₹ 19.0 Cr.
  • Current Price ₹ 0.70
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -211
  • Dividend Yield 0.00 %
  • ROCE -12.2 %
  • ROE %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Debtor days have improved from 42.9 to 32.1 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 2.07% over past five years.
  • Contingent liabilities of Rs.1,015 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018
87 113 95 88 96 91 95 89 88 80 84 82 95
82 99 84 94 92 86 94 82 84 78 80 70 84
Operating Profit 6 14 11 -6 4 5 0 7 4 2 4 12 11
OPM % 7% 12% 12% -7% 4% 5% 1% 7% 4% 3% 4% 15% 12%
0 3 1 0 1 1 1 2 1 -765 -3,008 2 1
Interest 89 83 80 95 97 98 103 112 111 114 237 148 -102
Depreciation 70 66 66 66 66 66 67 61 61 61 61 61 61
Profit before tax -153 -132 -134 -167 -158 -158 -167 -165 -168 -938 -3,303 -195 53
Tax % -35% -35% -35% -35% -35% -29% -35% 0% 0% -40% -30% -30% 30%
-100 -86 -88 -110 -103 -112 -110 -165 -168 -563 -2,309 -136 37
EPS in Rs -3.68 -3.17 -3.22 -4.02 -3.79 -4.12 -4.02 -6.05 -6.17 -20.69 -84.84 -5.00 1.36
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Dec 2013 Dec 2014 Mar 2016 15m Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
1,617 1,662 835 718 667 524 368 352 350 346 343 408
920 1,121 687 623 587 460 356 338 306 536 305 461
Operating Profit 697 541 148 95 80 64 13 14 44 -190 38 -53
OPM % 43% 33% 18% 13% 12% 12% 3% 4% 13% -55% 11% -13%
-52 9 6 4 4 8 4 -767 -3,008 4 75 8
Interest 230 270 412 438 470 415 370 440 259 0 0 2
Depreciation 198 252 259 254 277 345 264 246 246 246 245 243
Profit before tax 217 28 -518 -593 -662 -688 -617 -1,438 -3,468 -432 -133 -290
Tax % 33% 31% -32% -32% -31% -34% -33% -30% -4% 0% 536% 2%
145 19 -350 -401 -458 -450 -412 -1,005 -3,330 -432 -844 -295
EPS in Rs 5.42 0.71 -13.06 -14.96 -16.82 -16.55 -15.15 -36.94 -122.36 -15.89 -31.00 -10.85
Dividend Payout % 9% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -13%
5 Years: 2%
3 Years: 5%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 5%
3 Years: 3%
TTM: 65%
Stock Price CAGR
10 Years: -20%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Dec 2013 Dec 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity Capital 27 27 27 27 27 27 27 27 27 27 27 27
Reserves 2,444 2,464 1,844 1,443 1,010 1,637 1,249 249 -4,190 -4,623 -5,466 -5,760
3,744 4,255 4,990 5,868 6,105 6,568 6,949 7,493 3,223 7,969 7,900 7,984
433 389 223 61 70 129 130 109 4,642 123 130 181
Total Liabilities 6,648 7,134 7,084 7,399 7,213 8,360 8,355 7,877 3,703 3,495 2,591 2,432
2,845 2,942 3,633 3,433 3,274 2,965 2,726 2,488 2,244 1,998 1,760 1,520
CWIP 1,263 1,646 1,552 2,110 2,270 2,450 2,442 2,503 0 0 0 0
Investments 364 365 377 377 169 1,552 1,582 1,586 2 2 3 3
2,176 2,182 1,522 1,479 1,500 1,393 1,604 1,299 1,457 1,495 829 909
Total Assets 6,648 7,134 7,084 7,399 7,213 8,360 8,355 7,877 3,703 3,495 2,591 2,432

Cash Flows

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Dec 2013 Dec 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
348 370 811 172 256 67 1 -33 58 20 32 87
-994 -733 -812 -315 17 -84 -49 -9 -1 1 -4 1
675 227 -4 143 -273 16 49 38 -2 0 0 0
Net Cash Flow 29 -136 -4 -0 0 -1 0 -4 55 21 28 88

Ratios

Figures in Rs. Crores

Dec 2010 Dec 2011 Dec 2012 Dec 2013 Dec 2014 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 153 159 152 171 99 29 43 53 42 45 52 32
Inventory Days 313 419 547 566 498 739 939 88 91 101 134 117
Days Payable 23 18 17 14 19 23 51 30 35 25 36 28
Cash Conversion Cycle 442 559 682 722 577 745 931 112 98 121 149 121
Working Capital Days 427 124 -416 -952 -319 -393 -1,059 -4,086 -4,718 -4,985 -4,947 -4,279
ROCE % 9% 6% -2% -2% -3% -4% -3% -3% -6% -36% -5% -12%

Shareholding Pattern

Numbers in percentages

Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022
24.64% 24.64% 24.64% 24.64% 24.64% 24.64% 24.64% 24.64% 24.64% 24.64% 24.64% 24.64%
21.93% 21.93% 21.93% 21.93% 21.93% 21.93% 21.93% 21.93% 21.93% 21.93% 21.93% 21.92%
53.43% 53.43% 53.43% 53.43% 53.43% 53.43% 53.43% 53.43% 53.43% 53.43% 53.43% 53.43%
No. of Shareholders 35,16535,23335,24735,30135,29035,27135,25735,23835,23335,21635,20335,184

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

No data available.

Annual reports

Credit ratings